ONCR || Breast

VIDEO: Dr. William J. Gradishar provides take-home messages from ASCO 2015

Posted on: 04/06/2015 - 16:41

CHICAGO – Dr. William J. Gradishar says bevacizumab may not be dead, T-DM1 is definitely not dead, and the jury is still out on bisphosphonates preventing recurrence, based on presentations at the...

Field of Interest: Oncology

Type: News Item

Exercise pumps up chemotherapy completion rates for breast cancer patients

Posted on: 27/04/2015 - 21:00

Compared with usual care, a moderate- to high-intensity exercise intervention had beneficial effects on chemotherapy completion rates, symptom burden,... More »

Field of Interest: Oncology

Type: News Item

PD-L1 blockade breaks through triple-negative breast cancer

Posted on: 21/04/2015 - 20:32

Metastatic triple-negative breast cancer appears to be the latest hard-to-treat cancer to yield to the juggernaut that is now anti-PD-L1 immunotherapy... More »

Field of Interest: Oncology

Type: News Item

PD-L1 blockade breaks through triple-negative breast cancer

Posted on: 21/04/2015 - 20:32

Metastatic triple-negative breast cancer appears to be the latest hard-to-treat cancer to yield to the juggernaut that is now anti-PD-L1 immunotherapy... More »

Field of Interest: Pulmonology

Type: News Item

‘Task Force: Start biennial mammograms at age 50

Posted on: 20/04/2015 - 22:00

The U.S. Preventive Services Task Force is continuing to recommend routine mammograms every 2 years for women starting at age 50, according to newly r... More »

Field of Interest: Oncology

Type: News Item

‘Task Force: Start biennial mammograms at age 50

Posted on: 20/04/2015 - 22:00

The U.S. Preventive Services Task Force is continuing to recommend routine mammograms every 2 years for women starting at age 50, according to newly r... More »

Field of Interest: Pulmonology

Type: News Item

Type, location of BRCA mutations influence risk

Posted on: 07/04/2015 - 16:00

Among women who carry BRCA1 or BRCA2 mutations, the type and exact location of the mutation influences the risk it confers for breast and ovarian canc... More »

Field of Interest: Pulmonology

Type: News Item

Type, location of BRCA mutations influence risk

Posted on: 07/04/2015 - 16:00

Among women who carry BRCA1 or BRCA2 mutations, the type and exact location of the mutation influences the risk it confers for breast and ovarian canc... More »

Field of Interest: Oncology

Type: News Item

Physician-patient communication, terminology play important role in CPM decisions

Posted on: 30/03/2015 - 21:04

BIRMINGHAM, ALA. – The perception that one’s physician had recommended contralateral prophylactic mastectomy was a particularly important factor i... More »

Field of Interest: Oncology

Type: News Item

Physician-patient communication, terminology play important role in CPM decisions

Posted on: 30/03/2015 - 21:04

BIRMINGHAM, ALA. – The perception that one’s physician had recommended contralateral prophylactic mastectomy was a particularly important factor i... More »

Field of Interest: Pulmonology

Type: News Item

VIDEO: Dr. William J. Gradishar provides take-home messages from ASCO 2015

Exercise pumps up chemotherapy completion rates for breast cancer patients

PD-L1 blockade breaks through triple-negative breast cancer

PD-L1 blockade breaks through triple-negative breast cancer

‘Task Force: Start biennial mammograms at age 50

‘Task Force: Start biennial mammograms at age 50

Type, location of BRCA mutations influence risk

Type, location of BRCA mutations influence risk

Physician-patient communication, terminology play important role in CPM decisions

Physician-patient communication, terminology play important role in CPM decisions

Newsletters

Latest Newsletters

You are here

ONCR || Breast

Newsletters

Latest Newsletters